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http://www.biomedcentral.com/1472-6882/14/229RESEARCH ARTICLE Open AccessAloe vera attenuated liver injury in mice with
acetaminophen-induced hepatitis
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Naruemon Klaikeaw3, Rungsun Rerknimitr2 and Prasong Siriviriyakul1Abstract
Background: An overdose of the acetaminophen causes liver injury. This study aims to examine the anti-oxidative,
anti-inflammatory effects of Aloe vera in mice with acetaminophen induced hepatitis.
Methods: Male mice were randomly divided into three groups (n = 8 each). Control group were given orally
distilled water (DW). APAP group were given orally N-acetyl-P-aminophenol (APAP) 400 mg/kg suspended in DW.
Aloe vera-treated group were given orally APAP and Aloe vera (150 mg/kg) suspended in DW. Twenty-four hours
later, the liver was removed to determine hepatic malondialdehyde (MDA), hepatic glutathione (GSH), the number
of interleukin (IL)-12 and IL-18 positive stained cells (%) by immunohistochemistry method, and histopathological
examination. Then, the serum was collected to determine transaminase (ALT).
Results: In APAP group, ALT, hepatic MDA and the number of IL-12 and IL-18 positive stained cells were
significantly increased when compared to control group (1210.50 ± 533.86 vs 85.28 ± 28.27 U/L, 3.60 ± 1.50 vs 1.38
± 0.15 nmol/mg protein, 12.18 ± 1.10 vs 1.84 ± 1.29%, and 13.26 ± 0.90 vs 2.54 ± 1.29%, P = 0.000, respectively),
whereas hepatic GSH was significantly decreased when compared to control group (5.98 ± 0.30 vs 11.65 ± 0.43
nmol/mg protein, P = 0.000). The mean level of ALT, hepatic MDA, the number of IL-12 and IL-18 positive stained
cells, and hepatic GSH in Aloe vera-treated group were improved as compared with APAP group (606.38 ± 495.45 vs
1210.50 ± 533.86 U/L, P = 0.024; 1.49 ± 0.64 vs 3.60 ± 1.50 nmol/mg protein, P = 0.001; 5.56 ± 1.25 vs 12.18 ± 1.10%,
P = 0.000; 6.23 ± 0.94 vs 13.26 ± 0.90%, P = 0.000; and 10.02 ± 0.20 vs 5.98 ± 0.30 nmol/mg protein, P = 0.000,
respectively). Moreover, in the APAP group, the liver showed extensive hemorrhagic hepatic necrosis at all zones
while in Aloe vera-treated group, the liver architecture was improved histopathology.
Conclusions: APAP overdose can cause liver injury. Our result indicate that Aloe vera attenuate APAP-induced hepatitis
through the improvement of liver histopathology by decreased oxidative stress, reduced liver injury, and restored
hepatic GSH.
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An overdose of the analgesic drug acetaminophen causes
liver injury in experimental animals and humans. The tox-
icity has been shown to be initiated by cytochrome P450
metabolism to N-acetyl-p-benzoquinone imine (NAPQI)
[1,2]. The high reactivity of NAPQI with sulfhydryl groups
results in depleting glutathione in hepatocytes, followed by
covalent binding to intracellular proteins [3,4]. Although it* Correspondence: dr.duangporn@gmail.com
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article, unless otherwise stated.has been shown that the relative amount of covalent bind-
ing is correlated with the development of the toxicity [3],
it is also suggested that the covalent binding is not suffi-
cient for the toxicity [5-7]. Extensive studies were thus fo-
cused on covalent binding to specific proteins as a trigger
of the toxicity. A number of proteins have been identified
as targets of NAPQI by the immunological techniques [8]
and recent proteomics [9]. Because development of vari-
ous mitochondria dysfunctions has been observed with
acetaminophen toxicity, which include inhibition of res-
piration, a decrease in hepatic ATP levels, a decrease in
membrane potential, a loss of mitochondrial Ca2+ [10-13],Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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the reactive metabolite. Indeed, some of the target pro-
teins were localized in mitochondria fraction, including
glutamate dehydrogenase, aldehyde dehydrogenase, carba-
myl phosphate synthetase-I and ATP synthetase α-subunit
[8,9]. These enzyme activities in the mitochondrial frac-
tion were decreased partially [14,15], probably as conse-
quence of covalent binding, while it is also estimated that
only the loss of the any single enzyme activity could not
explain mitochondria-mediated acetaminophen hepato-
toxicity, it is thus presumed that the toxicity is accounted
for by combination of covalent binding to several func-
tional proteins and/or by secondary event following the
covalent binding.
A previous study demonstrated that APAP overdose
administration showed significantly increase in serum
transaminase, hepatic malondialdehyde (MDA), and de-
creased hepatic glutathione (GSH). Histological examin-
ation showed a severe centrilobular hepatic necrosis with
fatty changes [16-18].
Somanawat et al. [18] recently reported that adminis-
tration of APAP to mice resulted in a significant increase
in serum IL-12 and IL-18 expression and significant de-
crease in curcumin treatment, by using enzyme-linked
immunosorbent assay (ELISA) method.
Preliminary data obtained in animal models of APAP-
induced liver injury showed that the treatment with cur-
cumin could be effective in limiting liver injury, but the
exact mechanism of these effects is still largely undefined.
Interleukin-12 (IL-12) was originally indentified as a
natural killer (NK) cells stimulatory factor, a disulfide–
linked heterodimeric cytokine composed of 35 and 40
Ku subunits. IL-12 secreted principally by antigen pre-
senting cells (APC), such as macrophages, B cells, and
dendritic cells, activates NK cells and T cells to produce
interferon-γ (IFN-γ), and augments their cytotoxic activ-
ity and proliferation [19].
Interleukin-18 (IL-18), originally known as interferon-γ
(IFN-γ)-inducing factor (IGIF), is a cytokine that shares
structural and functional properties with interleukin-1
(IL-1) [20,21]. This cytokine is mainly produced by acti-
vated macrophages, but may also be expressed by Kupffer
cells, T cells, B cells, keratonocytes, astrocytes, and osteo-
blasts [22]. Like IL-1, IL-18 is synthesized as an inactive
precursor (pro-IL-18, 24 kDa), which is cleaved by interleukin-
1 β-converting enzyme (ICE or caspase-1) into an active
18 kDa mature form [22-24].
Aloe vera (Aloe barbadensis Mill) is classified in family
of Aloaceae, originated in the dry areas of Africa, Asia,
and Southern Europe, especially in the Mediterranean
regions. Aloe vera and other species of Aloe are succu-
lent and xerophytic plants that are adapted to living in
areas with little water. These plants possess extensive
water storage tissue in their leaves, the part of the plantwhich is used for its therapeutic properties [25]. The lar-
gest component (60%) in the dry matter, are the carbo-
hydrates (soluble sugar and complex polysaccharides).
Historically, Aloe vera has been known as a traditional
folklore medicine for the treatment of many diseases and
sicknesses. Aloe vera is a well-known anti-inflammatory
and wound-healer, accelerating the rapid growth of epithe-
lial tissue. Davis et al. [26] examined evidence that Aloe
vera is effective in treating wounds and reducing inflam-
mation by the action of mannose-6-phosphate (a major
sugar in Aloe gel), which they found to be an active
growth substance. Aloe vera is known to have a marked
effect in the treatment of scar tissue and the prevention of
scar formation following injury to the skin. This is because
Aloe vera stimulates cell production through the activity
of the amino acids, which are the basis for new cell forma-
tion, and also, due to the ability of its enzymes, promotes
regeneration at the deepest layers of the skin. Aloe vera
has also been used in the treatment of burns. It is sug-
gested that lectin may be responsible for the therapeutic
effect of the gel on burns [27]. Aloe vera can be used suc-
cessfully in the general treatment of skin ulcers, including
mouth ulcers, cold sores (herpes simplex), and leg ulcers.
This is possibly due to the anti-virucidal effect of the Aloe
vera gel at concentrations of about 80% [28]. Blitz et al.
[29] reported the use of Aloe vera gel internally taken to
treat peptic ulcers and disturbances of the gastrointestinal
tract. They attributed the gel effect to coacervation of pep-
sin inhibition of hydrochloric acid secretion and a general
detoxifying effect. In the field of dentistry, Aloe vera has
been used to treat a variety of dental conditions and has
been found to relieve pain and accelerate healing after
periodontal flap surgery [30]. The use of Aloe vera gel has
also been described in veterinary medicines. The gel ex-
tract has been used in the treatment of a number of exter-
nal conditions in many animals [31,32]. These conditions
include ringworm, allergies, abscesses, fungal infections,
various types of inflammation, pain, and itching. Anti-
oxidative and immunosuppressive activities of Aloe vera
have been indicated [33,34].
There are currently limited studies investigating the ef-
fects of Aloe vera on APAP-induced liver injury. However,
the effect of Aloe vera on IL-12 and IL18, in mice with
APAP-induced hepatitis has never been investigated.
Therefore, in this study, we determined whether Aloe vera
could attenuate liver injury in mice with APAP-induced
hepatitis and also influence IL-12 and IL-18, which is a
proinflammatory cytokines.
Methods
Animal care and diets
All experiments and procedures carried out on the ani-
mals were approved by the Ethics Committee of Faculty of
Medicine, Chulalongkorn University, Bangkok, Thailand.
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chased from the National Laboratory Animal Center,
Mahidol University (Bangkok, Thailand). Mice were housed
individually in stainless steel metabolic cages and main-
tained in an environmentally controlled room (25 ± 1°C)
under standard condition (12-hours dark–light cycle). Each
cage was equipped with a feeder and drinking water to
allow animal free access to food and drinking water. Mice
were fasted for 18 hours starting from 4.00 p.m. with ac-
cess to drinking water ad libitum before the experiment.
N-acetyl-P-aminophenol (APAP) and Aloe vera
preparations
A single dose of APAP tablet (Tylenol®) was suspended
in distilled water (DW) that was freshly prepared before
gavaging at the concentration of 400 mg/kg body weight
(b.w.). Lyophilized powder of Aloe vera was suspended
in DW at the concentration of 150 mg/kg b.w. (Lipo
Chemical Co, United States). The doses of APAP and Aloe
vera were used according to Somanawat et al. [18] and
minor adapted from Prabjone et al. [35], respectively. Oral
median lethal dose (LD50) values of APAP in multiple ani-
mal models are around 400 to 900 mg/kg b.w. (mice) and
more than 2,000 mg/kg b.w. (rat, rabbit, and guinea pig)
[36]. Oral LD50 value of Aloe vera in mice was estimated
to be 4.8 g/kg b.w. [37].
Preparation of fresh Aloe vera powder from Aloe vera gel
Leaves of 1-year old growing Aloe vera were cut and
washed thoroughly with water to exclude the drained
juice containing aloin. The edges of the leaves were cut,
and then split to extract the pulp which contains active
mucopolysaccharide substance. The pulp was then mixed
in a blender and sieved through fine gauze. Aloe vera gel
was kept in a refrigerator. The gel was changed into pow-
der form by freeze drying using a lyophilizer. The Aloe vera
powder was reconstituted into gel form and dispended in
DW before use.
Experimental design
After acclimatization for 7 days, mice were randomly di-
vided into three experimental groups: control (n = 8),
N-acetyl-P-aminophenol or APAP (n = 8), and Aloe vera-
treated group (n = 8) as follows.
Control group: Mice were given DW at the volume of
0.5 ml/mice orally via an intragastric tube once a day on
the 1st day and served as normal control.
APAP group: Mice were given APAP at the concentra-
tion of 400 mg/kg b.w. suspended in DW at the volume
of 0.5 mL/mice orally via an intragastric tube once a day
on the 1st day.
Aloe vera-treated group: Mice were given APAP at the
concentration of 400 mg/kg b.w. and Aloe vera at the
concentration of 150 mg/kg b.w. suspended in DW atthe volume of 0.5 mL/mice orally via an intragastric
tube once a day on the 1st day.
Mice anesthesia and care
Pre-anesthetic care reduces the incidence of complications
that can occur in the course of anesthesia by ensuring the
choice of the most suitable technique and regimen. As a
rule, animals purchased from external sources should be
singly housed for 1 or 2 weeks both to acclimate the ani-
mals and to allow time before an experiment for animal
care personnel to observe and evaluate the health of the
animals. Personnel attending the mice must be trained to
handle the animals gently but firmly because this handling
has a strong influence on the animals’ physiological func-
tions. Pre-anesthetic fasting in mice is generally deemed
unnecessary because the animals cannot vomit. Con-
versely, prolonged fasting can cause hypoglycemia due to
their low hepatic glycogen reserve. Some concern about
anesthetizing mice that have a full stomach is linked to
limited diaphragmatic excursion and to gastric blood pool-
ing during digestion.
Anesthesia in laboratory animals is a state of uncon-
sciousness, analgesia, muscle relaxation, and a-reflexia.
Induction of general anesthesia in mice can be achieved
by a variety of drugs and techniques. The most com-
monly used anesthetics in mice include the injectable
agent pentobarbital. In mice, injectable anesthetics can
best be administered via intraperitoneal (i.p.) route. The
injection volume should be carefully considered according
to the available route: adequate volumes by the i.p. route
range from 0.1 to 1 ml. During sedation and anesthesia, it
is imperative to carefully monitor and support mice body
temperature, heart and respiratory rates, mucous mem-
branes, and the degree of CNS depression. Anesthesia is
considered adequate when the animal stays still quietly, is
unresponsive to external stimuli, and has constant heart
and respiratory rates. In mice the absence of the palpebral
reflex suggests a fair anesthetic depth.
On the 2nd day or twenty-four hours after the experi-
ment, laparotomy was performed in mice under anesthesia
with i.p. injection of thiopental (50 mg/kg b.w.). The ab-
dominal wall was incised and liver was removed and wash
with cold normal saline (4°C- 8°C). The liver was chopped
into small pieces, frozen in liquid nitrogen, and stored
at −80°C to examine hepatic lipid peroxidation (MDA) and
GSH. The hepatic MDA was quantified by thiobarbituric
acid reaction as described by Ohkawa et al. [38]. The hep-
atic GSH was quantified by GSH Assay Kit (Cayman
Chemical Company, United States). The remaining liver
was isolated, fixed in 10% formalin solution to examine
histopathology and inflammatory cytokines, interleukin
(IL)-12 and IL-18, by immunohistochemistry method.
Then whole blood was withdrawn from heart. The
blood was allowed to coagulate at room temperature for
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tain serum. The serum was collected to examine trans-
aminase, serum glutamic oxaloacetic transaminase (SGOT)
and serum glutamic pyruvic transaminase (SGPT) by Reflo-
tron®Plus Clinical Chemistry analyzer (Roche, Switzerland).
Hepatic lipid peroxidation (MDA) assay
Lipid peroxidation of liver in mice using thiobarbituric
acid (TBA) was measured by a modified method of
Ohkawa et al. [38]. One gram of liver tissue was homog-
enized in 3 ml of 50 mM potassium phosphate buffer
(pH 7.0). To 0.3 ml of liver homogenated in test tube,
1.5 ml of 10% trichloroacetic acid (TCA) solution and
1.5 ml of 0.8% TBA solution were added. The mixture
was boiled in waterbath at 95°C for 60 minutes and then
cooling with water at room temperature. After centrifuga-
tion at 1000 × g for 15 minutes, the absorbance of sample
was measured at 532 nm. 1, 1, 3, 3 tetramethoxy propane
(TMP) was used as a standard of MDA. The MDA con-
tent was calculated in comparison with a standard MDA
curve and was expressed as nmol/mg protein.
Hepatic anti-oxidant (GSH) assay
Cayman’ GSH assay utilizes an optimized enzymatic re-
cycling method, using GSH reductase, for the quantifica-
tion of GSH. The sulfhydryl group of GSH reacts with 5,
5′-ditrio-bis-(2-nitrobenzoic acid) (DTNB), or Ellman’s
reagent and produces a yellow colored 5-thio-2-nitro-
benzoic acid (TNB). The mixed disulfide, GSTNB (be-
tween GSH and TNB) that is concomitantly produced, is
reduced by GSH reductase to recycle the GSH and pro-
duce more TNB. The production of TNB is directly pro-
portional to this recycling reaction which is in turn
directly proportional to the concentration of GSH in the
sample. The optical density (O.D.) of TNB is then mea-
sured at 405–414 nm using a microplate reader, which
provides an accurate estimation of GSH in the sample.
Histologic measurements of liver pathology
Sample of the liver were excised and transferred to for-
malin and later processed by routine techniques prior to
embedding in paraffin. Sections were cut at the thick-
ness of 5 μm and stained with hematoxylin and eosin
(H and E). An experienced pathologist blinded to the
experiment evaluated all samples. All histopathological
changes were observed under light microscope. Hep-
atic necroinflammation score in each section was graded
according to the criteria described by Brunt et al. [39]
from 0 to 3 as follow; Score 0 = No hepatocyte injury/
inflammation; Score 1 = Sparse or mild focal zone 3 hep-
atocyte injury/inflammation; Score 2 =Noticeable zone 3
hepatocyte injury/inflammation; Score 3 = Severe zone 3
hepatocyte injury/inflammation.Immunohistochemistry for inflammatory cytokines (IL-12
and IL-18) measurement
The liver sections were deparaffinized with xylene and
ethanol for ten minutes. After water washing, sections
retrieved the antigen with citrate buffer pH 6.0 in micro-
wave for thirteen minutes. Next, 3% H2O2 and 3% nor-
mal horse serum were performed on the slides to block
endogenous peroxidase activity for five minutes and
blocked nonspecific binding for twenty minutes, respect-
ively. Then, the primary antibody used for IL-12 and IL-
18, monoclonal antibodies against the Mouse IL-12 and
IL-18, were then applied at a dilution of 1:100 for IL-12
(R and D Systems, Inc., United States) and 1:200 for IL-18
(Gene Tex, United States) respectively for one hour at
room temperature and incubated with the secondary anti-
body for IL-12 (1:100; Dako, Denmark) and IL-18 (ready-
to-use; Dako, Denmark) for thirty minutes. When the de-
velopment of the color with diaminobenzidine (DAB) was
detected, the slides were counterstained with hematoxylin.
Under light microscopy (Nikon E50i, Nikon Corporation,
Japan), the number of positive cells presented dark brown
stained nuclei of liver Kupffer cells. Images were obtained
at × 20 and × 40 magnification field from each sample.
Ten images from two sections per animal were analyzed.
The numbers of positive stained cells were counted manu-
ally using Point tool in the IMAGE-PRO® PLUS software
program (version 6.1). A five hundred of macrophages or
liver Kupffer cells were counted for each sample. The re-
sults were expressed as the number of IL-12 and IL-18
Kupffer positive stained cells (%) calculating from this
equation:
The number of positive stained cells (%) ¼
number of nuclei stained cells




All data are presented as mean ± SD. We evaluated
group differences with one-way analysis of variance
(one-way ANOVA) followed by Tukey PostHoc com-
parision by using SPSS for windows version 17.0 (SPSS
Inc., Chicago, IL, United States). A P-value of < 0.05 was
considered significant.
Results
Change in serum SGOT and SGPT levels
Serum transaminase, SGOT and SGPT, are often used as
markers as their increase indicates liver damage. The
serum SGOT and SGPT levels were significantly in-
creased in APAP group when compared with control
group (1361.20 ± 290.26 vs 107.80 ± 38.66 U/L and
1210.50 ± 533.86 vs 85.28 ± 28.27 U/L, P = 0.000) and
significantly decreased in Aloe vera-treated group com-
pared with APAP group (458.62 ± 228.21 vs 1361.20 ±
Table 1 Summary of parameters in all experimental groups
Group/Parameters n IL-12 (%) IL-18 (%) SGOT SGPT MDA GSH
Control 8 1.84 ± 1.29 2.54 ± 1.29 107.80 ± 38.66 85.28 ± 28.27 1.38 ± 0.15 11.65 ± 0.43
APAP 8 12.18 ± 1.10a 13.26 ± 0.90a 1361.20 ± 290.26a 1210.50 ± 533.86a 3.60 ± 1.50a 5.98 ± 0.30a
Aloe vera-treated 8 5.56 ± 1.25b 6.23 ± 0.94b 458.62 ± 228.21a,b 606.38 ± 495.45c 1.49 ± 0.64d 10.02 ± 0.20a,b
The data were presented as the mean ± SD of serum SGOT, serum SGPT, hepatic GHS, hepatic MDA, and the number of IL-12 and IL-18 liver Kupffer positive
stained cells (%) in all experimental groups (n = 8). aP = 0.000 vs control group; bP = 0.000, cP = 0.024, and dP = 0.001 vs N-acetyl-P-aminophenol (APAP) group.
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533.86 U/L, P = 0.024) (Table 1 and Figure 1A, B).
Change in hepatic GSH level
GSH is essential for detoxification of APAP metabolites
and NAPQI that cause hepatic necroinflammation. Hep-
atic GSH was significantly decreased in APAP group when
compared with control group (5.98 ± 0.30 vs 11.65 ±
0.43 nmol/mg protein, P = 0.000). These were significantly
restored in Aloe vera-treated group when compared with
APAP group (10.02 ± 0.20 vs 5.98 ± 0.30 nmol/mg protein,
P = 0.000) (Table 1 and Figure 1C).
Change in hepatic MDA level
Hepatic MDA, which is the main metabolite in the intracel-
lular lipid peroxidation reaction significantly increased in
APAP group when compared with control group (3.60 ±A
B
C
Figure 1 The effects of Aloe vera on biological parameters in mice wi
oxaloacetic transaminase (SGOT). B: Serum glutamic pyruvic transaminase (
(MDA). E: Interleukin (IL)-12. F: Interleukin (IL)-18. aP = 0.000 vs control group
(APAP) group. 1: Control; 2: APAP; 3: Aloe vera-treated.1.50 vs 1.38 ± 0.15 nmol/mg protein, P = 0.000). These
were significantly decreased in Aloe vera-treated group
when compared with APAP group (1.49 ± 0.64 vs 3.60 ±
1.50 nmol/mg protein, P = 0.001) (Table 1 and Figure 1D).
Change in IL-12 and IL-18 levels
The expressions of both IL-12 and IL-18 in macrophages
or liver Kupffer cells were determined by immunohisto-
chemistry (IHC) method and showed as dark brown
stained nuclei of this cell.
The data of both IL-12 and IL-18 expressions in all
groups were given in Table 1 and Figures 1E, F, 2, 3.
From the result, the number of IL-12 and IL-18 positive
stained cells in the liver Kupffer cells of APAP group
was significantly higher than control group (12.18 ± 1.10
vs 1.84 ± 1.29% and 13.26 ± 0.90 vs 2.54 ± 1.29%, P = 0.000,
respectively). In contrast, Aloe vera-treated group (150 mg/D
E
F
th N-acetyl-P-aminophenol (APAP) overdose. A: Serum glutamic
SGPT). C: Hepatic glutathione (GSH). D: Hepatic malondialdehyde





Figure 2 Immunohistochemical staining of IL-12 antibody in the representative tissue specimens. A-B: Control. C-D: APAP. E-F: Aloe vera-treated.
Images were obtained at × 20 (A, C, and E) and × 40 (B, D, and F). DAB staining was used to highlight liver Kupffer cells in each section (dark brown
stain, arrows).
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nificantly when compared with APAP group (5.56 ± 1.25
vs 12.18 ± 1.10% and 6.23 ± 0.94 vs 13.26 ± 0.90%, P =
0.000, respectively).
Histopathology
In control group, hepatic necroinflammation score was 0
(n = 8) showed normal histology. In APAP group (n = 8),
the hepatic necroinflammation score was 2 (n = 2) and 3
(n = 6) that showed moderate and severe injury, respect-
ively. In Aloe vera-treated group (n = 8), the hepatic
necroinflammation score of was 1 (n = 4), 2 (n = 3), and
3 (n = 1) that showed improvement of severity (Table 2).
Histopathological examination of APAP group when
compared with control group showed acute centrilobular
hemorrhagic hepatic necrosis involving all zones. The
improvement of liver pathology revealed in Aloe vera-
treated group when compared with APAP group thatshowed focal necrosis and the classical hepatic architec-
ture was preserved (Figure 4).
Discussion
APAP-induced liver injury has reported in several mech-
anisms [40-42]. APAP undergoes metabolism to glucuro-
nide and sulfate conjugates, which are excreted in the
urine. Normally, only a small proportion (about 5%) of
APAP is oxidized to NAPQI that is detoxified by hepatic
GSH. Excessive doses of APAP (>7.5 g/day in adult or >
150 mg/kg in children) lead to the saturation of glucur-
onic acid and/or sulfate pathways shunting more APAP
into the cytochrome P450 (CYP) system [43]. The hepa-
torenal toxicity occurs when GSH reserves are depleted.
NAPQI binds cellular proteins including oxidation of
thiol groups in mitochondria leading to mitochondrial
permeability transition. The ensuing mitochondrial dys-





Figure 3 Immunohistochemical staining of IL-18 antibody in the representative tissue specimens. A-B: Control. C-D: APAP. E-F: Aloe
vera-treated. Images were obtained at × 20 (A, C, and E) and × 40 (B, D, and F) DAB staining was used to highlight liver Kupffer cells in each
section (dark brown stain, arrows).
Table 2 Summary of the hepatic necroinflammation score
in all experimental groups
Group n Hepatic necroinflammation scores
0 1 2 3
Control 8 8 0 0 0
APAP 8 0 0 2 6
Aloe vera-treated 8 0 4 3 1
Data are presented as the number of mice exhibiting each score of hepatic
necroinflammation (n = 8). Hepatic necroinflammation score in each section
was graded according to the criteria described by Brunt et al. [39] from 0 to 3
as follow; Score 0: No hepatocyte injury/inflammation; Score 1: Sparse or mild
focal zone 3 hepatocyte injury/ inflammation; Score 2: Noticeable zone 3
hepatocyte injury/inflammation; Score 3: Severe zone 3 hepatocyte injury/
inflammation.
APAP: N-acetyl-P-aminophenol.
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minate in nuclear and cytoplasmic swelling, cytoplas-
mic vacuolization, and mitochondrial swelling of both
hepatocytes and sinusoidal endothelial cells that fi-
nally cause apoptosis [44]. Immune mechanisms have
been increasingly implicated in APAP-induced hepato-
toxicity [45]. APAP-induced hepatocyte death leads to
the release of free DNA and the subsequent activation of
Toll-like receptor, increase production of interleukin-1
(IL-1) and other cytokines leading to neutrophil recruit-
ment. Lipid peroxidation of cell membrane results in de-
creasing of membrane fluidity, inability to restore ionic
gradients that finally cause cellular swelling or tissue
inflammation.
This study demonstrated that administration of N-
acetyl-P-aminophenol (APAP) or paracetamol overdose
induced hepatitis results in oxidative stress, liver injury,
liver histopathology, and hepatic GSH depletion in mice.
AB
C
Figure 4 The effects of Aloe vera improved liver histopathology
(hematoxylin and eosin stain). A: Control group showed normal
hepatic architecture (× 40). B: N-acetyl-P-aminophenol (APAP) group
showed acute centrilobular hemorrhagic hepatic necrosis through all
zones (zones 1, 2, and 3) (× 40). C: Aloe vera-treated group showed
focal necrosis with mild fatty changes and hepatic architecture was
well preserved with limited hepatic change (× 40). Arrows indicate
hepatic necrosis and CV indicate central vein.
Werawatganon et al. BMC Complementary and Alternative Medicine 2014, 14:229 Page 8 of 10
http://www.biomedcentral.com/1472-6882/14/229GSH is essential for detoxification of APAP metabolites
and NAPQI that cause hepatic necroinflammation. These
could be attenuated by treatment with Aloe vera extraction.
Our result corresponds to previous observations studied in
mice and rats models [16-18].
Aloe vera contains polysaccharide active substances “Ace-
mannan” and other anti-oxidative agents that prior animal-
model studies reporting about hepatoprotective effect in
alcoholic hepatitis or chemical-induced hepatotoxicity such
as carbon tetrachloride, lindane, azoxymethan, etc. [46]. In
this study, we found that Aloe vera extract results in
minimization of hepatic MDA level, which is the main me-
tabolite in the intracellular lipid peroxidation reaction. The
ability of Aloe vera to exert a significant and prevention on
the oxidative damage caused by APAP overdose when given
in mice confirms its anti-oxidative damage effect.
It has been reported that IL-12 is produced by dendritic
cells, monocytes, Langerhans cells, neutrophils, and kerati-
nocytes [19]. IL-18 is produced by activated macrophages,
keratinocytes, intestinal epithelial cells, oeteoblasts, adrenal
cortex cells, and the murine diencephalon. IL-18 is syn-
thesized as a precursor 24 kilodalton molecule without a
signal peptide and must be cleaved to produce an active
molecule. IL-1 converting enzyme (or caspase-1) cleaves
peo-IL-18, producing the mature bioactive peptide that is
readily released from cells [22,23,47-49].
Importantly, both of these cytokines are produced
from Kupffer cells or macrophages in the liver. It may be
possible that inflammation is due to hepatocytes releas-
ing cytokines into the blood stream. Furthermore, IL-12,
in combination with IL-18, causes inflammation via the
activity of interferon-gamma (IFN-γ), which is produced
by T-lymphocyte and NK cells.
Tangkijvanich et al. [48] reported that serum IL-12 level
was significantly higher in patients with hepatocellular
carcinoma (HCC) than in healthy controls by using
enzyme-linked immunosorbent assay (ELISA) method.
Furthermore, they found that its levels were correlation
with IL-18 level, suggesting that these cytokines may act
synergistically in the anti-tumor activity.
Our previous study demonstrated that curcumin ad-
ministration caused significantly elevated inflammatory
mediators, IL-12 and IL-18 levels, in the serum of mice
with APAP induced-hepatitis by using ELISA method
[18]. However, the effect of Aloe vera on inflammatory
mediators, IL-12 and IL-18, in animal models with APAP-
induced hepatitis has never been investigated.
In this study, we found significant rises in inflammatory
mediators, IL-12 and IL-18, in the liver Kupffer cells of
the APAP group compared to the control group through
increases the number of IL-12 and IL-18 positive stained
cells (%) by using immunohistochemistry method.
Thus, the detailed mechanisms of both IL-12 and IL-
18 involving in liver Kupffer cells inflammation should
Werawatganon et al. BMC Complementary and Alternative Medicine 2014, 14:229 Page 9 of 10
http://www.biomedcentral.com/1472-6882/14/229be further investigated. Moreover, treatment with Aloe
vera could attenuate liver injury in mice with APAP-
induced hepatitis. Despite its inconclusive mechanism of
action, we clearly demonstrated that Aloe vera has a pro-
tective and beneficial effect on APAP-induced hepatitis
in mice. Further study requires for confirm our hypoth-
esis and benefit of Aloe vera on the expression of these
inflammatory mediators in APAP-induced hepatitis in
animal model.
Conclusions
APAP could induce hepatitis through increases in oxida-
tive stress, hepatic GSH depletion, liver injury, and liver
histopathology. Aloe vera, an anti-inflammatory, anti-
oxidant, and curing wound herbal substance, could pre-
vent these adverse events and might be used as an
adjunctive therapy for APAP-induced hepatitis.
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